Anthony Beasley, a recent Worldwide Branding inductee, recently announced his participation in a campaign against bullying in the workplace.
Mr. Beasley will be a key presenter at this year’s Safety Institute of Australia ‘Visions’ Safety Conference on the Gold Coast which is taking place today, November 17, 2014. As part of the presentation’s pre-qualification processes, Mr. Beasley had to prepare a White Paper regarding the need for Accredited Training in the topic of “Managing and Preventing the Risk of Workplace Bullying.” This is because in Australia, there is currently no accredited competency-based program.
Mr. Beasley’s White Paper was accepted, and his team has supported him in the development of an excellent Prezi based presentation.
And in exploring beyond the White Paper, the topic generated such interest with Mr. Beasley’s team and clients, that he and his colleagues recently submitted a detailed application to the Australian Skills Regulator (ASQA) with two draft units to be accepted and released as nationally accredited. These are the first of their kind in Australia.
Mr. Beasley and his team has also prepared a media release to align with this exciting development in a topic that costs our economy between $6B to $36Billion per year, and has tragically taken lives for those on the receiving end of bullying.
Regardless of the country or industry – Mr. Beasley feels that the topic of bullying in the workplace is a subject that is of interest and value to all.
At the helm of Eriter Creations Inc., Karen L. Kennedy, Co-Owner and President of the company, works hard to invent and patent accessories for use in healthcare education. Her company offers “realistic and effective simulation [appendages] that mimic symptoms of health conditions to enhance and facilitate student and practitioner learning while eliminating the potential for harm to patients.” It was recently noted by the Journal of Emergency Medical Services that the use of human simulators has proven inventive, unproblematic, and painless for potential patients, professors, practitioners, and students, who are seeking to learn how to make medical procedures more safe and effective.
While Ms. Kennedy’s company specializes in the design and development of appendages and accessories, she has already garnered critical acclaim for breaking the mold as an inventor. The company was a first-place winner in the technical category for the best business plan for a sustainable business at the 2014 Chinook Entrepreneur Challenge.
Eriter Creations Inc. offers SimLeggings+ which simulate pitting edema, SimSleeves TM which simulate lymphedema, and a SimObesityShirt TM , which simulates adult obesity. These products have been used by nursing professors, and simulations have been put into effect with the use of these SimAccessories with medical professionals giving enthusiastic reviews about the products’ benefits.
If you would like to learn more about products being offered through Eriter Creations Inc., please visit http://www.simleggings.com.
Over the past four decades, Dr. Deborah S. Parris has distinguished herself as an authoritative figure in the fields of molecular virology and viral oncology. With her combined expertise in the fields of infectious diseases and cancer, Dr. Parris is prepared to provide expert scientific background and advice to pharmaceutical corporations, grant agencies, investment entities, and related corporations interested in the future of anti-infective and anti-cancer therapies.
The recent Ebola scare has driven people across the United States into a panic. However, Dr. Parris has already made a name for herself in the areas of molecular virology, immunology and medical genetics, having written a large number of peer-reviewed scientific publications. She is also a skilled grant writer and peer-reviewer. Dr. Parris has been a member of the faculty and Comprehensive Cancer Center at The Ohio State University for more than three decades, and she is now a professor in the Department of Molecular Virology, Immunology, and Medical Genetics at the College of Medicine. The research that is currently being conducted in her laboratory focuses on the suppression of RNA silencing by the Ebola virus. Dr. Parris’ contributions to the fields of herpes virus research and DNA replication fidelity are recognized nationally and internationally. Her research has been consistently funded by the National Institutes of Health and nonprofit agencies, such as the American Cancer Society.
In 2006, she was elected as a fellow of the American Association for the Advancement of Science, the world’s largest general scientific society and publisher of “Science” magazine. She has received numerous other awards including a Fogarty Senior International Fellowship, a Wellcome International Travel Fellowship, the Excellence in Research and Teaching award at the OSU College of Medicine, the James Champion Award for distinguished service to the OSU Comprehensive Cancer Center and the Sanford Goldston Memorial Research Award.
Read a research abstract co-authored by Dr. Parris in the “Journal of Virology” titled ‘Characterization of the RNA Silencing Suppression Activity of the Ebola Virus VP35 Protein in Plants and Mammalian Cells.’ Click here to read more research conducted by Dr. Parris.